CINXE.COM
Risk for new-onset diabetes mellitus after transplantation: | 11148
<!DOCTYPE html> <html lang="hi"> <head> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1"> <title>Risk for new-onset diabetes mellitus after transplantation: | 11148</title> <meta name="keywords" content="Moro O Salifu, Dale Distant, Dhiren M Haria, Mariya Stratilatova, Sheni Meghani, Joon Hong, Nabil Sumrani, Eli Friedman and Mariana S Markell, "/> <meta name="description" content="Background: The impact of the type of calcineurin inhibitor on the development of new-onset diabetes after transplantation (NODAT) has been difficult to as..11148"/> <meta name="citation_publisher" content="खुली पहुंच वाली पत्रिकाएँ" /> <meta name="citation_journal_title" content="क्लिनिक के जरिए डॉक्टर की प्रैक्टिस"> <meta name="citation_title" content="Risk for new-onset diabetes mellitus after transplantation: implication of advanced age and immunosuppressive therapy"> <meta name="citation_author" content="Moro O Salifu" /> <meta name="citation_author" content="Dale Distant" /> <meta name="citation_author" content="Dhiren M Haria" /> <meta name="citation_author" content="Mariya Stratilatova" /> <meta name="citation_author" content="Sheni Meghani" /> <meta name="citation_author" content="Joon Hong" /> <meta name="citation_author" content="Nabil Sumrani" /> <meta name="citation_author" content="Eli Friedman" /> <meta name="citation_author" content="Mariana S Markell" /> <meta name="citation_year" content=""> <meta name="citation_volume" content="2"> <meta name="citation_issue" content="4"> <meta name="citation_abstract" content="Background: The impact of the type of calcineurin inhibitor on the development of new-onset diabetes after transplantation (NODAT) has been difficult to assess due to contradictory results in published studies using heterogeneous populations. Aim: We attempted to assess the relative risk for development of NODAT in a population of age-stratified Afro–Caribbean and Hispanic renal-transplant recipients treated with cyclosporin A (CSA) or tacrolimus in an urban academic medical center (n = 284). Patients & methods: Patients, based on age distribution, were divided into group 1 (20–44 years; n = 85); group 2 (45–56 years; n = 110); and group 3 (57–79 years; n = 85). Results: In each age group, tacrolimus-treated patients had significantly higher rates of NODAT (7, 17 and 15%) compared with CSA-treated patients (2, 9 and 7%); p = 0.015. The risk of NODAT was increased in age group 2 (hazard ratio: 4.7; 95% confidence interval: 2.0–11.0; p = 0.01) and group 3 (hazard ratio :3.4; 95% confidence interval: 1.4–8.5; p = 0.01) compared with group 1 and use of tacrolimus compared with CSA (hazard ratio: 2.7; 95% confidence interval: 1.4–5.0; p = 0.01). Race, gender, acute rejection episodes and other demographic factors were insignificant factors between the age groups. Conclusion: We conclude that, in our population, the risk of NODAT increases with age and use of tacrolimus. Discrepancies in assigning risk to immunosuppressive regimens in previous studies may be confounded by the analysis of mixed age groups or predominantly younger patients. "> <meta name="citation_abstract_html_url" content="https://hindi.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html"> <!-- Mobile Metas --> <meta name="viewport" content="width=device-width, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no"> <meta name="google-site-verification" content="ypsp6Oyy1tkpCl6LCSMCdwfqE92cK2o1aql3UJuuoA8" /> <link rel="canonical" href="https://hindi.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html"> <link rel="alternate" href="https://hindi.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" hreflang="hi"/> <meta name="ROBOTS" content="INDEX,FOLLOW"> <meta name="googlebot" content="INDEX,FOLLOW"> <!-- GLOBAL MANDATORY STYLES --> <link href='https://fonts.googleapis.com/css?family=Roboto:100,400,700,500,300,300italic' rel='stylesheet' type='text/css'> <link href='https://fonts.googleapis.com/css?family=Droid+Serif:400,400italic,700,700italic' rel='stylesheet' type='text/css'> <link href="/assets/plugins/bootstrap/css/bootstrap.min.css" rel="stylesheet" type="text/css"/> <!-- <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/4.5.2/css/bootstrap.min.css"> --> <link href="/assets/plugins/et-line/et-line.css" rel="stylesheet" type="text/css"/> <link href="/assets/plugins/font-awesome/css/font-awesome.min.css" rel="stylesheet" type="text/css"/> <!-- END GLOBAL MANDATORY STYLES --> <link href="/assets/css/global.css" rel="stylesheet" type="text/css"/> <link href="/assets/css/custom.css" rel="stylesheet" type="text/css"/> <link href="/assets/css/author.css" rel="stylesheet" type="text/css"/> <!-- BEGIN JQUERY --> <script async type="text/javascript" src="/assets/plugins/jquery.min.js"></script> <!--END JQUERY---> <script async type="text/javascript" src="/assets/plugins/bootstrap/js/bootstrap.min.js"></script> <!-- FAVICON --> <link rel="shortcut icon" href="/favicon.ico"/> <!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-29271993-8"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-7QFQW3G4VV'); </script> </head> <body> <div class="wrapper"> <header class="header header-sticky"> <div class="search-field"> <div class="container"> <input type="text" class="form-control search-field-input" placeholder="Search for..."> </div> </div> <!-- End Search Field --> <!-- Navbar --> <nav class="navbar mega-menu" role="navigation"> <div class="container"> <!-- Brand and toggle get grouped for better mobile display --> <div class="menu-container"> <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".nav-collapse"> <span class="sr-only">Toggle navigation</span> <span class="toggle-icon"></span> </button> <!-- Navbar Actions --> <div class="navbar-actions"> <!-- Search --> <div class="navbar-actions-shrink search"> <div class="search-btn"> <i class="search-btn-default ti-search"></i> <i class="search-btn-active ti-close"></i> </div> </div> <!-- End Search --> </div> <!-- End Navbar Actions --> <!-- Logo --> <div class="navbar-logo"> <a class="navbar-logo-wrap" href="https://hindi.openaccessjournals.com/" title="Open Access Journals"> <img class="navbar-logo-img" src="https://hindi.openaccessjournals.com/images/logo.png" alt="खुली पहुंच वाली पत्रिकाएँ"> </a> </div> <!-- End Logo --> </div> <div class="collapse navbar-collapse nav-collapse"> <div class="menu-container"> <ul class="nav navbar-nav"> <li class="nav-item"> <a class="nav-item-child" href="https://hindi.openaccessjournals.com/journals/clinical-practice.html" title="यहाँ क्लिक करें">घर</a> </li> <li class="nav-item dropdown"> <a class="nav-item-child dropdown-toggle" href="javascript:void(0);" data-toggle="dropdown" title="यहाँ क्लिक करें"> लेखक दिशानिर्देश <i class="fa fa-angle-down fa-lg"></i></a> <ul class="dropdown-menu own-menu"> <li class="dropdown-menu-item"><a class="dropdown-menu-item-child" href="https://hindi.openaccessjournals.com/journals/clinical-practice-guidelines.html" title="यहाँ क्लिक करें">लेखक दिशानिर्देश</a></li> <li class="dropdown-menu-item"><a class="dropdown-menu-item-child" href="https://hindi.openaccessjournals.com/journals/clinical-practice-aims-and-scope.html" title="यहाँ क्लिक करें">उद्देश्य और दायरा</a></li> <li class="dropdown-menu-item"><a class="dropdown-menu-item-child" href="https://hindi.openaccessjournals.com/journals/clinical-practice-peer-review-process.html" title="यहाँ क्लिक करें">समकक्ष समीक्षा प्रक्रिया</a></li> <li class="dropdown-menu-item"><a class="dropdown-menu-item-child" href="https://hindi.openaccessjournals.com/journals/clinical-practice-ethical-malpractices.html" title="यहाँ क्लिक करें">प्रकाशन नैतिकता एवं कदाचार वक्तव्य</a></li> </ul> </li> <li class="nav-item"> <a class="nav-item-child" href="https://hindi.openaccessjournals.com/journals/clinical-practice-archive.html" title="यहाँ क्लिक करें">पुरालेख</a> </li> <li class="nav-item"> <a class="nav-item-child" href="https://hindi.openaccessjournals.com/journals/clinical-practice-submitmanuscript.html" title="यहाँ क्लिक करें">पांडुलिपि जमा करें</a> </li> <!---languages drop down----> <li class="nav-item dropdown multi_lang j_multi_lang"> <a class="nav-link dropdown-toggle" href="#" id="multi_lang" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Language </a> <div class="dropdown-menu" aria-labelledby=""> <a class="dropdown-item" href="https://www.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="English"> <img src="https://www.openaccessjournals.com/admin/flags/usa.png">English </a> <a class="dropdown-item" href="https://spanish.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="Spanish"> <img src="https://www.openaccessjournals.com/admin/flags/spain.png">Spanish </a> <a class="dropdown-item" href="https://chinese.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="Chinese"> <img src="https://www.openaccessjournals.com/admin/flags/china.png">Chinese </a> <a class="dropdown-item" href="https://russian.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="Russian"> <img src="https://www.openaccessjournals.com/admin/flags/russia.png">Russian </a> <a class="dropdown-item" href="https://german.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="German"> <img src="https://www.openaccessjournals.com/admin/flags/germany.png">German </a> <a class="dropdown-item" href="https://french.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="French"> <img src="https://www.openaccessjournals.com/admin/flags/france.png">French </a> <a class="dropdown-item" href="https://japanese.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="Japanese"> <img src="https://www.openaccessjournals.com/admin/flags/japan.png">Japanese </a> <a class="dropdown-item" href="https://portuguese.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="Portuguese"> <img src="https://www.openaccessjournals.com/admin/flags/portugal.png">Portuguese </a> <a class="dropdown-item" href="https://telugu.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="Telugu"> <img src="https://www.openaccessjournals.com/admin/flags/india.png">Telugu </a> <a class="dropdown-item" href="https://tamil.openaccessjournals.com/abstract/risk-for-newonset-diabetes-mellitus-after-transplantation-implication-of-advanced-age-and-immunosuppressive-therapy-11148.html" title="Tamil"> <img src="https://www.openaccessjournals.com/admin/flags/india.png">Tamil </a> </div> </li> <!---languages drop down----> </ul> </div> </div> </div> </nav> </header> <div class="whatup"> <ul> <li><a href="tel:+44-330-822-4832">+44-330-822-4832<i class="fa fa-whatsapp" aria-hidden="true"></i></a></li> </ul> </div> <!--========== Breadcrumbs v5 ==========--> <section class="breadcrumbs-v5"> <div class="container"> <div class="row"> <div class="col-md-3 sm-margin-b-30"> <p class="font-size-24 fweight-400" id="issn"> आईएसएसएन: 2044-9038 (Print) 2044-9046 (Electronic) </p> </div> <div class="col-md-7 sm-margin-b-30"> <h2 class="breadcrumbs-v5-title">क्लिनिक के जरिए डॉक्टर की प्रैक्टिस</h2> </div> </div> </div> </section> <style> .breadcrumbs-v5 { position: relative; z-index: 1; background: url(https://www.openaccessjournals.com/admin/banners/clinical-practice-therapy-banner.jpg) no-repeat; background-size: cover; background-position: 50% 20%; padding: 80px 0 80px; text-align:center; } .breadcrumbs-v5 .breadcrumbs-v5-title { font-size: 60px; } #issn{ line-height:30px; color:#fff; } </style> <div class="bg-color-sky-light"> <!--========== PAGE CONTENT ==========--> <div class="content container"> <div class="row"> <div class="col-md-12 md-margin-b-50"> <!-- Blog Grid --> <article class="blog-grid margin-b-30"> <div class="blog-grid-content"> <!-- <h2 class="blog-grid-title-lg">Abstract</h2> --> <h3 class="blog-grid-title-lg">अमूर्त</h3> <h1 class="fweight-400 font-size-26"> Risk for new-onset diabetes mellitus after transplantation: implication of advanced age and immunosuppressive therapy </h1> Moro O Salifu, Dale Distant, Dhiren M Haria, Mariya Stratilatova, Sheni Meghani, Joon Hong, Nabil Sumrani, Eli Friedman and Mariana S Markell<br /><br /> <p style=\"\\"text-align:\">Background: The impact of the type of calcineurin inhibitor on the development of new-onset diabetes after transplantation (NODAT) has been difficult to assess due to contradictory results in published studies using heterogeneous populations. Aim: We attempted to assess the relative risk for development of NODAT in a population of age-stratified Afro–Caribbean and Hispanic renal-transplant recipients treated with cyclosporin A (CSA) or tacrolimus in an urban academic medical center (n = 284). Patients & methods: Patients, based on age distribution, were divided into group 1 (20–44 years; n = 85); group 2 (45–56 years; n = 110); and group 3 (57–79 years; n = 85). Results: In each age group, tacrolimus-treated patients had significantly higher rates of NODAT (7, 17 and 15%) compared with CSA-treated patients (2, 9 and 7%); p = 0.015. The risk of NODAT was increased in age group 2 (hazard ratio: 4.7; 95% confidence interval: 2.0–11.0; p = 0.01) and group 3 (hazard ratio :3.4; 95% confidence interval: 1.4–8.5; p = 0.01) compared with group 1 and use of tacrolimus compared with CSA (hazard ratio: 2.7; 95% confidence interval: 1.4–5.0; p = 0.01). Race, gender, acute rejection episodes and other demographic factors were insignificant factors between the age groups. Conclusion: We conclude that, in our population, the risk of NODAT increases with age and use of tacrolimus. Discrepancies in assigning risk to immunosuppressive regimens in previous studies may be confounded by the analysis of mixed age groups or predominantly younger patients.</p> <div class="alert alert-info text-left"><b>:</b> </div> </div> </article> </div> </div> </div> </div> <!--========== FOOTER V2 ==========--> <footer id="footer" class="cu_footer"> <div class="container"> <div class="row padding-t-20 padding-b-20"> <div class="col-md-10"> <ul> <li ><a href="https://hindi.openaccessjournals.com/">घर</a></li> <li ><a href="https://hindi.openaccessjournals.com/about-us.html">हमारे बारे में</a></li> <li ><a href="https://hindi.openaccessjournals.com/journals.html">पत्रिकाओं</a></li> <li ><a href="https://hindi.openaccessjournals.com/instructionsforauthors.html">लेखक दिशानिर्देश</a></li> <li ><a href="https://hindi.openaccessjournals.com/contact-us.html">संपर्क करें</a></li> </ul> <!-- End Menu List --> </div> <div class="col-md-2"> <!-- Theme Icons Base On Hover --> <ul class="list-inline ul-li-lr-2 text-right sm-text-center margin-b-0"> <li class="animate-theme-icons"> <a class="animate-theme-icons-body animate-theme-icons-white-bg theme-icons-md radius-3" href="https://www.facebook.com/profile.php?id=100076418779107" target="_blank"> <i class="animate-theme-icons-element fa fa-facebook"></i> </a> </li> <li class="animate-theme-icons"> <a class="animate-theme-icons-body animate-theme-icons-white-bg theme-icons-md radius-3" href="https://twitter.com/OpenaccessJ" target="_blank"> <i class="animate-theme-icons-element fa fa-twitter"></i> </a> </li> <li class="animate-theme-icons"> <a class="animate-theme-icons-body animate-theme-icons-white-bg theme-icons-md radius-3" href="https://www.linkedin.com/company/open-access-journal" target="_blank"> <i class="animate-theme-icons-element fa fa-linkedin"></i> </a> </li> <li class="animate-theme-icons"> <a class="animate-theme-icons-body animate-theme-icons-white-bg theme-icons-md radius-3" href="https://www.instagram.com/openaccess_journals/" target="_blank"> <i class="animate-theme-icons-element fa fa-instagram"></i> </a> </li> </ul> <!-- End Theme Icons Base On Hover --> </div> </div> <!-- Copyright --> <div class="footer-v2-copyright"> <p class="pclas"><a href="https://hindi.openaccessjournals.com/" title="यहाँ क्लिक करें" class="color-white">खुली पहुंच वाली पत्रिकाएँ</a> © 2025</p> </div> <!-- End Copyright --> </div> <div class="app-view"> Get the App <p><a href="https://play.google.com/store/apps/details?id=com.journals.openaccessjournals" target="_blank"><i class="fa fa-android" aria-hidden="true"></i></a></p> </div> </footer> <!--========== END FOOTER V2 ==========--> <!-- END WRAPPER --> <!-- Sidebar Content Overlay --> <div class="sidebar-content-overlay"></div> <!-- End Sidebar Content Overlay --> <!-- Back To Top --> <a href="javascript:void(0);" class="js-back-to-top back-to-top-theme"></a> <script async type="text/javascript" src="https://hindi.openaccessjournals.com/assets/plugins/jquery.migrate.min.js"></script> <script async type="text/javascript" src="https://hindi.openaccessjournals.com/assets/plugins/bootstrap/js/bootstrap.min.js"></script> <!-- END CORE PLUGINS --> <!-- BEGIN PAGE LEVEL PLUGINS --> <script async type="text/javascript" src="https://hindi.openaccessjournals.com/assets/plugins/jquery.back-to-top.js"></script> <script async type="text/javascript" src="https://hindi.openaccessjournals.com/assets/plugins/jquery.equal-height.js"></script> <!-- BEGIN PAGE LEVEL SCRIPTS --> <!-- END PAGE LEVEL SCRIPTS --> <script async src="https://app.wabi-app.com/widget/js/wabi.js?phone_number=+44-1704-335730&lang=en&position=left"></script> <!--========== END JAVASCRIPTS ==========--></div> </body> </html>